Peter Palese

Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Microbiology Biology
"Peter Palese"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Martínez JL, Lemus N, Lai TY, et al. (2024) The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex. Vaccine
Van Reeth K, Parys A, Gracia JCM, et al. (2023) Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine. Nature Communications. 14: 7745
Edgar JE, Trezise S, Anthony RM, et al. (2023) Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo. Proceedings of the National Academy of Sciences of the United States of America. 120: e2314905120
Puente-Massaguer E, Vasilev K, Beyer A, et al. (2023) Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice. Science Advances. 9: eadi4753
Puente-Massaguer E, Beyer A, Loganathan M, et al. (2023) Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses. Frontiers in Bioengineering and Biotechnology. 11: 1097349
Sánchez-de Prada L, Sanz-Muñoz I, Sun W, et al. (2023) Group 1 and group 2 hemagglutinin stalk antibody response according to age. Frontiers in Immunology. 14: 1194073
Ponce-de-León S, Torres M, Soto-Ramírez LE, et al. (2023) Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico. Npj Vaccines. 8: 67
Widge AT, Hofstetter AR, Houser KV, et al. (2023) An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Science Translational Medicine. 15: eade4790
Carreño JM, Raskin A, Singh G, et al. (2023) An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science Translational Medicine. 15: eabo2847
Meade P, Strohmeier S, Bermúdez-González MC, et al. (2022) Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity. Journal of Virology. e0107022
See more...